Global Stem Cell Therapy for Diabetes and Related Conditions Supply, Demand and Key Producers, 2023-2029

Description

Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).

This report studies the global Stem Cell Therapy for Diabetes and Related Conditions demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Stem Cell Therapy for Diabetes and Related Conditions, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Stem Cell Therapy for Diabetes and Related Conditions that contribute to its increasing demand across many markets.

The global Stem Cell Therapy for Diabetes and Related Conditions market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

NSI-566 is the stem cell therapy candidate under development by one of the key companies Neuralstem. The molecule is being developed for the treatment of individuals with diabetic neuropathy and is currently in the pre-clinical development stage. The mechanism of action of this stem cell therapy includes cell replacement that eventually leads to neurogenesis stimulation.

Highlights and key features of the study
Global Stem Cell Therapy for Diabetes and Related Conditions total market, 2018-2029, (USD Million)
Global Stem Cell Therapy for Diabetes and Related Conditions total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Stem Cell Therapy for Diabetes and Related Conditions total market, key domestic companies and share, (USD Million)
Global Stem Cell Therapy for Diabetes and Related Conditions revenue by player and market share 2018-2023, (USD Million)
Global Stem Cell Therapy for Diabetes and Related Conditions total market by Type, CAGR, 2018-2029, (USD Million)
Global Stem Cell Therapy for Diabetes and Related Conditions total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Stem Cell Therapy for Diabetes and Related Conditions market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Athersys, Mesoblast, Caladrius Biosciences, Sanofi and Novo Nordisk, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Stem Cell Therapy for Diabetes and Related Conditions market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Stem Cell Therapy for Diabetes and Related Conditions Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Stem Cell Therapy for Diabetes and Related Conditions Market, Segmentation by Type
    Monotherapy
    Combination Therapy

Global Stem Cell Therapy for Diabetes and Related Conditions Market, Segmentation by Application
    Type 1 Diabetes Mellitus
    Type 2 Diabetes Mellitus
    Diabetic Foot Ulcer
    Diabetic Nephropathy
    Diabetic Neuropathy

Companies Profiled:
    Athersys
    Mesoblast
    Caladrius Biosciences
    Sanofi
    Novo Nordisk

Key Questions Answered
1. How big is the global Stem Cell Therapy for Diabetes and Related Conditions market?
2. What is the demand of the global Stem Cell Therapy for Diabetes and Related Conditions market?
3. What is the year over year growth of the global Stem Cell Therapy for Diabetes and Related Conditions market?
4. What is the total value of the global Stem Cell Therapy for Diabetes and Related Conditions market?
5. Who are the major players in the global Stem Cell Therapy for Diabetes and Related Conditions market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Stem Cell Therapy for Diabetes and Related Conditions Introduction
    1.2 World Stem Cell Therapy for Diabetes and Related Conditions Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Stem Cell Therapy for Diabetes and Related Conditions Total Market by Region (by Headquarter Location)
        1.3.1 World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)
        1.3.3 China Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)
        1.3.4 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)
        1.3.5 Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)
        1.3.6 South Korea Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)
        1.3.7 ASEAN Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)
        1.3.8 India Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Stem Cell Therapy for Diabetes and Related Conditions Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Stem Cell Therapy for Diabetes and Related Conditions Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029)
    2.2 World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value by Region
        2.2.1 World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value by Region (2018-2023)
        2.2.2 World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Forecast by Region (2024-2029)
    2.3 United States Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029)
    2.4 China Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029)
    2.5 Europe Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029)
    2.6 Japan Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029)
    2.7 South Korea Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029)
    2.8 ASEAN Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029)
    2.9 India Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029)

3 World Stem Cell Therapy for Diabetes and Related Conditions Companies Competitive Analysis
    3.1 World Stem Cell Therapy for Diabetes and Related Conditions Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Stem Cell Therapy for Diabetes and Related Conditions Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Stem Cell Therapy for Diabetes and Related Conditions in 2022
        3.2.3 Global Concentration Ratios (CR8) for Stem Cell Therapy for Diabetes and Related Conditions in 2022
    3.3 Stem Cell Therapy for Diabetes and Related Conditions Company Evaluation Quadrant
    3.4 Stem Cell Therapy for Diabetes and Related Conditions Market: Overall Company Footprint Analysis
        3.4.1 Stem Cell Therapy for Diabetes and Related Conditions Market: Region Footprint
        3.4.2 Stem Cell Therapy for Diabetes and Related Conditions Market: Company Product Type Footprint
        3.4.3 Stem Cell Therapy for Diabetes and Related Conditions Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Stem Cell Therapy for Diabetes and Related Conditions Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Stem Cell Therapy for Diabetes and Related Conditions Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Comparison
        4.2.1 United States VS China: Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Stem Cell Therapy for Diabetes and Related Conditions Companies and Market Share, 2018-2023
        4.3.1 United States Based Stem Cell Therapy for Diabetes and Related Conditions Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue, (2018-2023)
    4.4 China Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue and Market Share, 2018-2023
        4.4.1 China Based Stem Cell Therapy for Diabetes and Related Conditions Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue, (2018-2023)
    4.5 Rest of World Based Stem Cell Therapy for Diabetes and Related Conditions Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Stem Cell Therapy for Diabetes and Related Conditions Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Stem Cell Therapy for Diabetes and Related Conditions Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Monotherapy
        5.2.2 Combination Therapy
    5.3 Market Segment by Type
        5.3.1 World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2018-2023)
        5.3.2 World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2024-2029)
        5.3.3 World Stem Cell Therapy for Diabetes and Related Conditions Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Stem Cell Therapy for Diabetes and Related Conditions Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Type 1 Diabetes Mellitus
        6.2.2 Type 2 Diabetes Mellitus
        6.2.3 Diabetic Foot Ulcer
        6.2.4 Diabetic Nephropathy
        6.2.5 Diabetic Nephropathy
    6.3 Market Segment by Application
        6.3.1 World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2018-2023)
        6.3.2 World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2024-2029)
        6.3.3 World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Athersys
        7.1.1 Athersys Details
        7.1.2 Athersys Major Business
        7.1.3 Athersys Stem Cell Therapy for Diabetes and Related Conditions Product and Services
        7.1.4 Athersys Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Athersys Recent Developments/Updates
        7.1.6 Athersys Competitive Strengths & Weaknesses
    7.2 Mesoblast
        7.2.1 Mesoblast Details
        7.2.2 Mesoblast Major Business
        7.2.3 Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Product and Services
        7.2.4 Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Mesoblast Recent Developments/Updates
        7.2.6 Mesoblast Competitive Strengths & Weaknesses
    7.3 Caladrius Biosciences
        7.3.1 Caladrius Biosciences Details
        7.3.2 Caladrius Biosciences Major Business
        7.3.3 Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Product and Services
        7.3.4 Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Caladrius Biosciences Recent Developments/Updates
        7.3.6 Caladrius Biosciences Competitive Strengths & Weaknesses
    7.4 Sanofi
        7.4.1 Sanofi Details
        7.4.2 Sanofi Major Business
        7.4.3 Sanofi Stem Cell Therapy for Diabetes and Related Conditions Product and Services
        7.4.4 Sanofi Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Sanofi Recent Developments/Updates
        7.4.6 Sanofi Competitive Strengths & Weaknesses
    7.5 Novo Nordisk
        7.5.1 Novo Nordisk Details
        7.5.2 Novo Nordisk Major Business
        7.5.3 Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Product and Services
        7.5.4 Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Novo Nordisk Recent Developments/Updates
        7.5.6 Novo Nordisk Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Stem Cell Therapy for Diabetes and Related Conditions Industry Chain
    8.2 Stem Cell Therapy for Diabetes and Related Conditions Upstream Analysis
    8.3 Stem Cell Therapy for Diabetes and Related Conditions Midstream Analysis
    8.4 Stem Cell Therapy for Diabetes and Related Conditions Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Stem Cell Therapy for Diabetes and Related Conditions Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Stem Cell Therapy for Diabetes and Related Conditions Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Stem Cell Therapy for Diabetes and Related Conditions Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Stem Cell Therapy for Diabetes and Related Conditions Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Stem Cell Therapy for Diabetes and Related Conditions Players in 2022
    Table 12. World Stem Cell Therapy for Diabetes and Related Conditions Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Stem Cell Therapy for Diabetes and Related Conditions Company Evaluation Quadrant
    Table 14. Head Office of Key Stem Cell Therapy for Diabetes and Related Conditions Player
    Table 15. Stem Cell Therapy for Diabetes and Related Conditions Market: Company Product Type Footprint
    Table 16. Stem Cell Therapy for Diabetes and Related Conditions Market: Company Product Application Footprint
    Table 17. Stem Cell Therapy for Diabetes and Related Conditions Mergers & Acquisitions Activity
    Table 18. United States VS China Stem Cell Therapy for Diabetes and Related Conditions Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Stem Cell Therapy for Diabetes and Related Conditions Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share (2018-2023)
    Table 23. China Based Stem Cell Therapy for Diabetes and Related Conditions Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Stem Cell Therapy for Diabetes and Related Conditions Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share (2018-2023)
    Table 29. World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2024-2029) & (USD Million)
    Table 35. Athersys Basic Information, Area Served and Competitors
    Table 36. Athersys Major Business
    Table 37. Athersys Stem Cell Therapy for Diabetes and Related Conditions Product and Services
    Table 38. Athersys Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Athersys Recent Developments/Updates
    Table 40. Athersys Competitive Strengths & Weaknesses
    Table 41. Mesoblast Basic Information, Area Served and Competitors
    Table 42. Mesoblast Major Business
    Table 43. Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Product and Services
    Table 44. Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Mesoblast Recent Developments/Updates
    Table 46. Mesoblast Competitive Strengths & Weaknesses
    Table 47. Caladrius Biosciences Basic Information, Area Served and Competitors
    Table 48. Caladrius Biosciences Major Business
    Table 49. Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Product and Services
    Table 50. Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Caladrius Biosciences Recent Developments/Updates
    Table 52. Caladrius Biosciences Competitive Strengths & Weaknesses
    Table 53. Sanofi Basic Information, Area Served and Competitors
    Table 54. Sanofi Major Business
    Table 55. Sanofi Stem Cell Therapy for Diabetes and Related Conditions Product and Services
    Table 56. Sanofi Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Sanofi Recent Developments/Updates
    Table 58. Novo Nordisk Basic Information, Area Served and Competitors
    Table 59. Novo Nordisk Major Business
    Table 60. Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Product and Services
    Table 61. Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 62. Global Key Players of Stem Cell Therapy for Diabetes and Related Conditions Upstream (Raw Materials)
    Table 63. Stem Cell Therapy for Diabetes and Related Conditions Typical Customers
List of Figure
    Figure 1. Stem Cell Therapy for Diabetes and Related Conditions Picture
    Figure 2. World Stem Cell Therapy for Diabetes and Related Conditions Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Stem Cell Therapy for Diabetes and Related Conditions Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Stem Cell Therapy for Diabetes and Related Conditions Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Stem Cell Therapy for Diabetes and Related Conditions Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Stem Cell Therapy for Diabetes and Related Conditions Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Stem Cell Therapy for Diabetes and Related Conditions Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Stem Cell Therapy for Diabetes and Related Conditions Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Stem Cell Therapy for Diabetes and Related Conditions Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Stem Cell Therapy for Diabetes and Related Conditions Revenue (2018-2029) & (USD Million)
    Figure 13. Stem Cell Therapy for Diabetes and Related Conditions Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Stem Cell Therapy for Diabetes and Related Conditions Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Stem Cell Therapy for Diabetes and Related Conditions by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Stem Cell Therapy for Diabetes and Related Conditions Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Stem Cell Therapy for Diabetes and Related Conditions Markets in 2022
    Figure 27. United States VS China: Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Stem Cell Therapy for Diabetes and Related Conditions Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Stem Cell Therapy for Diabetes and Related Conditions Market Size Market Share by Type in 2022
    Figure 31. Monotherapy
    Figure 32. Combination Therapy
    Figure 33. World Stem Cell Therapy for Diabetes and Related Conditions Market Size Market Share by Type (2018-2029)
    Figure 34. World Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Stem Cell Therapy for Diabetes and Related Conditions Market Size Market Share by Application in 2022
    Figure 36. Type 1 Diabetes Mellitus
    Figure 37. Type 2 Diabetes Mellitus
    Figure 38. Diabetic Foot Ulcer
    Figure 39. Diabetic Nephropathy
    Figure 40. Diabetic Neuropathy
    Figure 41. Stem Cell Therapy for Diabetes and Related Conditions Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source